Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6AF65

Entry ID Method Resolution Chain Position Source
AF-Q6AF65-F1 Predicted AlphaFoldDB

No variants for Q6AF65

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6AF65

No associated diseases with Q6AF65

3 regional properties for Q6AF65

Type Name Position InterPro Accession
domain LexA repressor, DNA-binding domain 16 - 78 IPR006199
domain Peptidase S24/S26A/S26B/S26C 110 - 223 IPR015927
domain LexA-like 144 - 216 IPR039418

Functions

Description
EC Number 2.5.1.145 Transferring alkyl or aryl groups, other than methyl groups
Subcellular Localization
  • Cell membrane ; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

1 GO annotations of molecular function

Name Definition
phosphatidylglycerol-prolipoprotein diacylglyceryl transferase activity Catalysis of the transfer of the diacylglyceryl group from phosphatidylglycerol to the sulfhydryl group of the prospective N-terminal cysteine residue in an unmodified prolipoprotein.

1 GO annotations of biological process

Name Definition
lipoprotein biosynthetic process The chemical reactions and pathways resulting in the formation of any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSSWMASIPS PGPEWAQIHL PFLPFRIQTY ALIILTGIVV AAMWTSRRLT KRGAEPGVVL
70 80 90 100 110 120
DVLLWAVPLG IIGARLYHVV THPADFFYPG ANVWNPFQPG AIWNIWEGGN AIFGALIGGA
130 140 150 160 170 180
VGVGIGCRWT GLRFWTFADA LAPALLLAQA IGRLGNYVNQ ELFGLPTSLP WGLEIASGNK
190 200 210 220 230 240
AIPVGLPEGT LFQPLFLYEI VWNVIGVFVI LWLERRFRLQ WGRVLAVYLI WYGLGRSYLE
250 260 270 280 290 300
SIRIDPSEFS FLGIPSNVWA AFAAVVLGAI ILRVQAQRHT GLEPGPYLPG REWVSPQAEV
310 320 330
ESGETDPEEI LHADDDEERT GTHKPQATSL SGSN